Trial intelligence / Profile preview

Lacosamide Long-term Safety in Pediatric Focal Epilepsy (China Extension)

CTR20160914Phase 3Completed

Sponsor
UCB
Start
May 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lacosamide in Focal Onset Epilepsy, sponsored by UCB. Started May 2018; status: completed.

02

Drugs

lacosamide
03

Conditions

Focal Onset Epilepsy

Beyond the preview

Go deeper on CTR20160914.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160914.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call